IL28B rs12979860 polymorphism and zinc supplementation affect treatment outcome and liver fibrosis after direct-acting antiviral hepatitis C therapy

BACKGROUND: Impact of interleukin 28B (IL28B) rs12979860 polymorphism on response to direct-acting antivirals agents in HCV genotype 4-infected patients is under investigation. Zinc may have an advantage in improvement of liver damage and treatment outcome. We aimed to evaluate IL28B polymorphism an...

Descripción completa

Detalles Bibliográficos
Autores principales: Attallah, Abdelfattah M., Omran, Dalia, Abdelrazek, Mohamed A., Hassany, Mohamed, Saif, Sameh, Farid, Aza, El Essawey, Riham, Ghaffar, Muhammad Abdel, Aabdelghany, Marwa, Yosry, Ayman
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8501168/
https://www.ncbi.nlm.nih.gov/pubmed/34623551
http://dx.doi.org/10.1186/s43141-021-00250-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8501168/
https://www.ncbi.nlm.nih.gov/pubmed/34623551
http://dx.doi.org/10.1186/s43141-021-00250-y

Ejemplares similares